# HS 300439 Containing Hormones (But Not Insulin global trade...

Reported global trade in containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale reached $44.3B in 2024, with five-year annual growth of +6.9%.

## Annual trade evidence

| Year | Global trade | Year-on-year growth | 3-year growth |
| --- | --- | --- | --- |
| 2013 | $21.5B | +10.7% | +9.7% |
| 2014 | $22.6B | +5.1% | +5.7% |
| 2015 | $21.2B | -6.3% | +3% |
| 2016 | $23.2B | +9.5% | +2.6% |
| 2017 | $24.8B | +6.7% | +3.1% |
| 2018 | $28.0B | +13% | +9.7% |
| 2019 | $31.7B | +13.1% | +10.9% |
| 2020 | $35.8B | +13% | +13.1% |
| 2021 | $38.0B | +6.2% | +10.7% |
| 2022 | $37.0B | -2.8% | +5.3% |
| 2023 | $38.8B | +4.9% | +2.7% |
| 2024 | $44.3B | +14.2% | +5.2% |

## Leading buyer markets

| Buyer market | Latest imports | 5-year growth | Suppliers |
| --- | --- | --- | --- |
| USA | $9.3B | +1.7% | 43 |
| China | $3.0B | +17.6% | 40 |
| United Kingdom | $3.0B | +31.6% | 53 |
| Germany | $2.8B | +12.4% | 58 |
| Switzerland, Liechtenstein | $2.7B | -0% | 48 |
| France | $2.4B | +19% | 64 |
| Japan | $1.8B | +10.2% | 37 |
| Italy | $1.7B | -12.4% | 55 |
| Belgium | $1.6B | -7.8% | 54 |
| Spain | $1.2B | +14.1% | 37 |
| Brazil | $1.2B | +19.6% | 35 |
| Denmark | $1.2B | +30.7% | 31 |

_Source: reported merchandise trade data. Updated 2026-08-14._